CHEMOMAB Trademark

Trademark Overview


On Sunday, January 9, 2022, a trademark application was filed for CHEMOMAB with the United States Patent and Trademark Office. The USPTO has given the CHEMOMAB trademark a serial number of 79335096. The federal status of this trademark filing is REGISTERED as of Tuesday, July 11, 2023. This trademark is owned by Chemomab Therapeutics Ltd.. The CHEMOMAB trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and medicinal products for the treatment of inflammatory, fibrotic, and autoimmune diseases

Providing medical research information, namely, biological, chemical, pharmaceutical, and clinical data in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals for treatment of fibrotic diseases, autoimmune diseases, and inflammatory diseases; research and development of pharmaceuticals for the treatment of fibrotic diseases, inflammatory diseases, autoimmune diseases
chemomab

General Information


Serial Number79335096
Word MarkCHEMOMAB
Filing DateSunday, January 9, 2022
Status700 - REGISTERED
Status DateTuesday, July 11, 2023
Registration Number7102415
Registration DateTuesday, July 11, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2023

Trademark Statements


Goods and ServicesPharmaceutical and medicinal products for the treatment of inflammatory, fibrotic, and autoimmune diseases
Goods and ServicesProviding medical research information, namely, biological, chemical, pharmaceutical, and clinical data in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals for treatment of fibrotic diseases, autoimmune diseases, and inflammatory diseases; research and development of pharmaceuticals for the treatment of fibrotic diseases, inflammatory diseases, autoimmune diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 7, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameChemomab Therapeutics Ltd.
Party Type30 - Original Registrant
Legal Entity Type78 - NOT AVAILABLE
AddressTel Aviv - Yafo 6158002
IL

Party NameChemomab Therapeutics Ltd.
Party Type20 - Owner at Publication
Legal Entity Type78 - NOT AVAILABLE
AddressTel Aviv - Yafo 6158002
IL

Party NameChemomab Therapeutics Ltd.
Party Type10 - Original Applicant
Legal Entity Type78 - NOT AVAILABLE
AddressTel Aviv - Yafo 6158002
IL

Trademark Events


Event DateEvent Description
Tuesday, October 31, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, October 12, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 12, 2023FINAL DISPOSITION PROCESSED
Wednesday, October 11, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 11, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 11, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, April 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2023PUBLISHED FOR OPPOSITION
Monday, April 24, 2023NOTIFICATION PROCESSED BY IB
Wednesday, April 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 5, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 17, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 7, 2023REFUSAL PROCESSED BY IB
Friday, January 13, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 13, 2023REFUSAL PROCESSED BY MPU
Thursday, November 3, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 2, 2022NON-FINAL ACTION WRITTEN
Monday, October 17, 2022ASSIGNED TO EXAMINER
Friday, March 11, 2022APPLICATION FILING RECEIPT MAILED
Monday, March 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 3, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB